SB 154, legislation prohibiting pharmaceutical manufacturers from interfering in contracts between 340B entities and pharmacies, passed the Senate and passed the House Health and Human Services Committee with 8-5 vote.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.